Genenta Science SpA ADR Cash Flow-to-Debt Ratio
Genenta Science SpA ADR cash flow-to-debt ratio. Genenta Science SpA ADR (GNTA) has a Cash Flow-to-Debt Ratio of -0.17x as of March 2026, meaning its operating cash flow of $-1.69 Million could theoretically repay 0% of its total liabilities ($10.05 Million) in one year. See Genenta Science SpA ADR free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Genenta Science SpA ADR (2019–2025)
Cash flow-to-debt ratio of Genenta Science SpA ADR from 2019 to 2025. Historical debt coverage capacity for Genenta Science SpA ADR across 7 annual periods. Also explore net asset growth rate of Genenta Science SpA ADR to track the company's year-over-year net asset growth rate.
Genenta Science SpA ADR Cash Flow-to-Debt Ratio by Year (2019–2025)
Genenta Science SpA ADR cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Genenta Science SpA ADR. For the full cash flow conversion analysis, see cash flow conversion of Genenta Science SpA ADR.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.68x | $-6.87 Million | $10.05 Million | ▲ +74.5% |
| 2024 | -2.68x | $-6.24 Million | $2.33 Million | ▲ +54.2% |
| 2023 | -5.85x | $-11.21 Million | $1.91 Million | ▼ -81.4% |
| 2022 | -3.23x | $-7.42 Million | $2.30 Million | ▲ +46.0% |
| 2021 | -5.97x | $-6.96 Million | $1.17 Million | ▼ -132.2% |
| 2020 | -2.57x | $-6.04 Million | $2.35 Million | ▼ -157.9% |
| 2019 | -1.00x | $-2.49 Million | $2.50 Million | — |